- Published at
- by gurufocus.com
neutral
neutral
ABVC BioPharma Inc Reports Q1 2025 Net Loss Per Share of $(0.06) and Strategic Cost Reductions
On May 1, 2025, ABVC BioPharma Inc (ABVC) released its 8-K filing detailing the financial results for the first quarter ending March 31, 2025. ABVC BioPharma In